Pembrolizumab (NSCLC): Powder for injection 50 mg; Keytruda® Page last updated: 23 March 2017 Public Summary Document (PSD) November 2016 PBAC Meeting - (PDF 616KB) Public Summary Document (PSD) November 2016 PBAC Meeting - (Word 355KB)